Andrew J. Fromkin insider trades

Open-market stock purchases and sales by Andrew J. Fromkin, Director at Immunovant, Inc, from SEC Form 4 filings since Nov 14, 2013.

Recent trades

DateStockTradeValue
May 28, 2026IMVT Immunovant, IncSold$375K
May 28, 2026IMVT Immunovant, IncSold$7.1M
May 28, 2026IMVT Immunovant, IncBought (not open market)—
May 28, 2026IMVT Immunovant, IncBought (not open market)—
May 28, 2026IMVT Immunovant, IncBought (not open market)—
May 28, 2026IMVT Immunovant, IncBought (not open market)—
Apr 7, 2026IMVT Immunovant, IncBought (not open market)—
Apr 7, 2026IMVT Immunovant, IncBought (not open market)—
Dec 1, 2025IMVT Immunovant, IncSold$448K
Dec 1, 2025IMVT Immunovant, IncSold$69.4K

Companies traded

  • IMVT Immunovant, Inc: 1 buy, 9 sales, last May 28, 2026
  • TBRA Tobira Therapeutics, Inc: other filings, last Nov 1, 2016
  • RGDO Regado Biosciences Inc: other filings, last Jan 1, 2015
  • NONE Radius Health, Inc: other filings, last Nov 14, 2013

Get free alerts when Andrew J. Fromkin files a new trade →